Takayasu's arteritis pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(37 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Takayasu's arteritis}}
{{Takayasu's arteritis}}
{{CMG}} {{AE}} {{FKH}}
{{CMG}} {{AE}} {{FKH}}


==Overview==
==Overview==
The [[pathogenesis]] of Takayasu's arteritis is poorly understood. Takayasu's arteritis characterized by segmental and patchy [[Granuloma|granulomatous]] [[inflammation]] of the [[aorta]] and its major derivative branches.This [[inflammation]] leads to [[Artery|arterial]] [[stenosis]], [[thrombosis]], and [[Aneurysm|aneurysms]]. Three factors that have been suggested to have association with susceptibility, development and progression of Takayasu's arteritis are [[Genetics|genetic]] influences, [[Immunology|immunologic]] mechanisms, and relationship to [[tuberculosis]]. The most important conditions associated with Takayasu's arteritis include [[ankylosing spondylitis]], [[inflammatory bowel disease]], and [[Behçet's disease|Behçet's syndrome]]. On gross pathology, stiff and rigid [[aorta]] on [[palpation]], gelatinous appearance of thickened [[adventitia]], and sharp line of demarcation between normal and diseased segments might be seen. On microscopic [[histopathological]] analysis characteristic findings of Takayasu's arteritis include [[inflammation]] around the [[vasa vasorum]] and at the medio-adventitial junction, [[edema]] of the [[Tunica media|media]] and [[adventitia]], [[Large cell|giant cell]] [[Granuloma|granulomatous]] reaction, [[laminar necrosis]], and [[Fragmentation (reproduction)|fragmentation]] of [[Elastic fiber|elastic fibers]].


==Pathophysiology==
==Pathophysiology==
* The pathogenesis of Takayasu's arteritis is poorly understood.<ref name="pmid10737351">{{cite journal |vauthors=Inder SJ, Bobryshev YV, Cherian SM, Wang AY, Lord RS, Masuda K, Yutani C |title=Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions |journal=Cardiovasc Surg |volume=8 |issue=2 |pages=141–8 |date=March 2000 |pmid=10737351 |doi= |url=}}</ref>
* The [[pathogenesis]] of Takayasu's arteritis is poorly understood.<ref name="pmid10737351">{{cite journal |vauthors=Inder SJ, Bobryshev YV, Cherian SM, Wang AY, Lord RS, Masuda K, Yutani C |title=Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions |journal=Cardiovasc Surg |volume=8 |issue=2 |pages=141–8 |date=March 2000 |pmid=10737351 |doi= |url=}}</ref>
* Three factors have been suggested that have associated with disease susceptibility, development and progression:  
* Granulomatous [[inflammation]] of the [[aorta]] and its major branches might lead to Takayasu's arteritis.
* [[Cell-mediated immunity|Cell-mediated]] mechanisms are considered as a main pathogenesis mechanism of Takayasu's arteritis and it is similar to [[giant cell arteritis]].
* This [[inflammation]] leads to [[arterial]] [[stenosis]], [[thrombosis]], and [[Aneurysm|aneurysms]].
* Irregular [[fibrosis]] of the [[Blood vessel|blood vessels]] due to chronic [[vasculitis]] may lead to [[Tunica intima|intimal]] [[fibrosis]].
* There are three factors that have associated with disease susceptibility, development and progression:  
** Relationship to [[tuberculosis]] (TB)
** Relationship to [[tuberculosis]] (TB)
** Genetic influences  
** [[Genetics|Genetic]] influences  
** Immunologic mechanisms
** [[Immunology|Immunologic]] mechanisms
'''Relationship to tuberculosis (TB)'''
'''Relationship to tuberculosis (TB)'''
* It has been suggested that Takayasu arteritis is associated with TB. Following evidences support this [[hypothesis]]:<ref name="pmid12655">{{cite journal |vauthors=Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE |title=Takayasu's arteritis. Clinical study of 107 cases |journal=Am. Heart J. |volume=93 |issue=1 |pages=94–103 |date=January 1977 |pmid=12655 |doi= |url=}}</ref>


[[Granulomatous]] inflammation with the Langhans-type of [[giant cells]] in many cases of Takayasu arteritis and the intermittent coexistence of Takayasu arteritis with pulmonary and extrapulmonary tuberculosis, support this idea. However,the absence of [[mycobacterial]] organisms in arteritic lesions and the lack of response to anti-tuberculus therapy suggest that perhaps [[hypersensitivity]] to the tuberculus organism may play a role in the pathogenesis of Takayasu arteritis.<ref name="pmid12655" />
** [[Granulomatous]] [[Inflammation|inflammation]] with the [[Langhans giant cells|Langhans-type of giant cells]] in many cases of Takayasu arteritis  
 
** Intermittent coexistence of Takayasu arteritis with [[Lung|pulmonary]] and [[extrapulmonary tuberculosis]]
** [[Hypersensitivity]] to the [[tuberculosis]] organism
'''Genetic influences'''
'''Genetic influences'''
* Geographic distribution of Takayasu arteritis, with high [[prevalence]] in Japan and Korea, suggests that [[Genetics|genetic]] factors are probably play a role in the [[pathogenesis]] of Takayasu arteritis.


* Takayasu arteritis has been associated with different [[human leukocyte antigen]] ([[Human leukocyte antigen|HLA]]) [[Allele|alleles]] in different populations. In Japan and Korea, there is a clear association with the extended [[haplotype]]:<ref name="pmid10980348">{{cite journal |vauthors=Salazar M, Varela A, Ramirez LA, Uribe O, Vasquez G, Egea E, Yunis EJ, Iglesias-Gamarra A |title=Association of HLA-DRB1*1602 and DRB1*1001 with Takayasu arteritis in Colombian mestizos as markers of Amerindian ancestry |journal=Int. J. Cardiol. |volume=75 Suppl 1 |issue= |pages=S113–6 |date=August 2000 |pmid=10980348 |doi= |url=}}</ref>
**[[HLA-B]]*52
**[[HLA-DRB1]]*1502
**[[HLA-DRB5]]*0102
**[[HLA-DQA1]]*0103
**[[HLA-DQB1]]*0601
**[[HLA-DP]]A1*02
**[[HLA-DPB1]]*0901
'''Immunologic mechanisms'''
'''Immunologic mechanisms'''
* Takayasu's arteritis characterized by segmental and patchy [[Granuloma|granulomatous]] [[inflammation]] of the aorta and its major derivative branches.
* Cell-mediated mechanisms are thought to be of primary importance and may be similar to those in giant cell arteritis.
* This inflammation leads to arterial [[stenosis]], [[thrombosis]], and [[Aneurysm|aneurysms]].
* Immunohistopathologic examination has shown that the infiltrating cells in aortic tissue mainly consist of killer cells, especially gamma delta T lymphocytes 
* These cells may cause vascular injury by releasing large amounts of the cytolytic compound perforin
* There is also irregular fibrosis of the blood vessels due to chronic vasculitis, leading to sometimes massive intimal fibrosis.
* Seko ''et al'' have reported that γδT cells, αβT cells (CD4 and CD8), and natural killer cells play an important role in the vascular injury.<ref name="pmid10980341">{{cite journal |vauthors=Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R |title=Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis |journal=Int. J. Cardiol. |volume=75 Suppl 1 |issue= |pages=S77–83; discussion S85–7 |date=August 2000 |pmid=10980341 |doi= |url=}}</ref>
* Infection has been considered to play a role in the pathogenesis of Takayasu arteritis. Tuberculosis has been particularly implicated in view of the high prevalence of infection, past or present, in affected patients,largely from endemic areas.<ref name="pmid12655">{{cite journal |vauthors=Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE |title=Takayasu's arteritis. Clinical study of 107 cases |journal=Am. Heart J. |volume=93 |issue=1 |pages=94–103 |date=January 1977 |pmid=12655 |doi= |url=}}</ref>
* Takayasu arteritis has been associated with different human leucocyte antigen (HLA) alleles in different populations.
* in Japan and Korea there is a clear association with the extended haplotype: HLA B*52, DRB1*1502, DRB5*0102, DQA1*0103, DQB1*0601, DPA1*02-DPB1*0901.<ref name="pmid10980348">{{cite journal |vauthors=Salazar M, Varela A, Ramirez LA, Uribe O, Vasquez G, Egea E, Yunis EJ, Iglesias-Gamarra A |title=Association of HLA-DRB1*1602 and DRB1*1001 with Takayasu arteritis in Colombian mestizos as markers of Amerindian ancestry |journal=Int. J. Cardiol. |volume=75 Suppl 1 |issue= |pages=S113–6 |date=August 2000 |pmid=10980348 |doi= |url=}}</ref>


* The genetic contribution to the pathogenesis of Takayasu's arteritis is supported by the genetic association with HLA-B∗52.
Because of rheumatic-type complaints in many Takayasu arteritis patients, the relationship between Takayasu arteritis and [[Autoimmunity|autoimmune]] and [[collagen]] [[vascular]] disorders has been suggested.
* no specific autoantigens have yet been identified and for any adaptive immune response to occur, whether against exogenous or endogenous antigen, presentation of antigen to T cells in the context of the major histocompatibility complex is central.
* Immunohistopathologic examination has shown that the infiltrating cells in [[Aorta|aortic]] tissue mainly consist of [[Natural killer cell|killer cells]], especially gamma delta [[T lymphocytes]]. 
* These cells may cause [[vascular injury]] by releasing large amounts of the cytolytic compound [[perforin]].
* It has been reported that γδT cells, αβT cells ([[CD4]] and [[CD8]]), and [[Natural killer cell|natural killer cells]] play an important role in the [[vascular injury]].<ref name="pmid10980341">{{cite journal |vauthors=Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R |title=Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis |journal=Int. J. Cardiol. |volume=75 Suppl 1 |issue= |pages=S77–83; discussion S85–7 |date=August 2000 |pmid=10980341 |doi= |url=}}</ref>
* No specific [[Autoantigen|autoantigens]] have yet been identified.
== Associations ==
* The most important conditions associated with Takayasu's arteritis include:
* The most important conditions associated with Takayasu's arteritis include:
** Ankylosing spondylitis(AS)
** [[Ankylosing spondylitis]]
** Inflammatory bowel disease (IBD)
** [[Inflammatory bowel disease]] (IBD)
** Behçet's syndrome (BS)
** [[Behçet's disease|Behçet's syndrome]]
A recent large collaborative study uncovered multiple additional susceptibility loci for this disease, increasing the number of genetic loci for this disease to five risk loci across the genome. About 200,000 genetic variants were genotyped in two ethnically divergent Takayasu's arteritis cohorts from Turkey and North America by using a custom-designed genotyping platform (Immunochip). Additional genetic variants and the classical HLA alleles were imputed and analyzed. The study identified and confirmed two independent susceptibility loci within the HLA region (r2 < 0.2): HLA-B/MICA (rs12524487, OR = 3.29, p = 5.57 × 10-16) and HLA-DQB1/HLA-DRB1 (rs113452171, OR = 2.34, p = 3.74 × 10-9; and rs189754752, OR = 2.47, p = 4.22 × 10-9). In addition, a genetic association was identified and confirmed between Takayasu's arteritis and the FCGR2A/FCGR3A locus on chromosome 1 (rs10919543, OR = 1.81, p = 5.89 × 10-12). The risk allele in this locus results in increased mRNA expression of FCGR2A. In addition, a genetic association between IL12B and Takayasu arteritis was established (rs56167332, OR = 1.54, p = 2.18 × 10-8). A fifth genetic locus for the disease on chromosome 21q22 downstream of PSMG1 was also revealed (P=4.39X10-7)
== Gross pathology ==
On gross pathology characteristic findings of Takayasu's arteritis are as follows:<ref name="pmid10980333">{{cite journal |vauthors=Gravanis MB |title=Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors |journal=Int. J. Cardiol. |volume=75 Suppl 1 |issue= |pages=S21–33; discussion S35–6 |date=August 2000 |pmid=10980333 |doi= |url=}}</ref>
* Stiff and rigid [[aorta]] on [[palpation]]
* Gelatinous appearance of thickened [[adventitia]]
* Enlarged [[Paraaortic lymph node|para-aortic]] [[Lymph node|lymph nodes]] in the area of [[Renal artery|renal]] and [[Subclavian artery|subclavian arteries]]
* [[Glycosaminoglycan|<nowiki/><nowiki/>]]Sharp line of demarcation between normal and diseased segments[[Glycosaminoglycan|<nowiki/><nowiki/>]]
== Microscopic pathology ==
On microscopic [[histopathological]] analysis characteristic findings of Takayasu's arteritis are as follows:<ref name="pmid10980333" />
* [[Inflammation]] around the [[vasa vasorum]] and at the medio-adventitial junction
* [[Edema]] of the [[Tunica media|media]] and [[adventitia]]
* [[Large cell|Giant cell]] [[Granuloma|granulomatous]] reaction
* [[Laminar necrosis]]
* [[Fragmentation (biology)|Fragmentation]] of [[Elastic fiber|elastic fibers]]
* Rapid or more severe [[inflammation]] leads to:
** Loss of [[smooth muscle cell]]<nowiki/>s
** Medial weakening
** [[Vascular]] dilatation
** [[Aneurysm]] formation
[[Image:Vasculitis.jpg|300px|left|thumb|H & E microscopy of a vessel showing vasculitis (inflammatory cells within the vessel wall), source:https://librepathology.org/wiki/Vasculitides#Takayasu_arteritis]]
<br style="clear:left">


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Arthritis]]
[[Category:Medicine]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Disease]]
[[Category:Up-To-Date]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 13:19, 24 May 2018

Takayasu's arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Takayasu's arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Takayasu's arteritis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Takayasu's arteritis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Takayasu's arteritis pathophysiology

on Takayasu's arteritis pathophysiology

Takayasu's arteritis pathophysiology in the news

Blogs onTakayasu's arteritis pathophysiology

Directions to Hospitals Treating Takayasu's arteritis

Risk calculators and risk factors for Takayasu's arteritis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]

Overview

The pathogenesis of Takayasu's arteritis is poorly understood. Takayasu's arteritis characterized by segmental and patchy granulomatous inflammation of the aorta and its major derivative branches.This inflammation leads to arterial stenosisthrombosis, and aneurysms. Three factors that have been suggested to have association with susceptibility, development and progression of Takayasu's arteritis are genetic influences, immunologic mechanisms, and relationship to tuberculosis. The most important conditions associated with Takayasu's arteritis include ankylosing spondylitis, inflammatory bowel disease, and Behçet's syndrome. On gross pathology, stiff and rigid aorta on palpation, gelatinous appearance of thickened adventitia, and sharp line of demarcation between normal and diseased segments might be seen. On microscopic histopathological analysis characteristic findings of Takayasu's arteritis include inflammation around the vasa vasorum and at the medio-adventitial junction, edema of the media and adventitia, giant cell granulomatous reaction, laminar necrosis, and fragmentation of elastic fibers.

Pathophysiology

Relationship to tuberculosis (TB)

  • It has been suggested that Takayasu arteritis is associated with TB. Following evidences support this hypothesis:[2]

Genetic influences

  • Geographic distribution of Takayasu arteritis, with high prevalence in Japan and Korea, suggests that genetic factors are probably play a role in the pathogenesis of Takayasu arteritis.

Immunologic mechanisms

Because of rheumatic-type complaints in many Takayasu arteritis patients, the relationship between Takayasu arteritis and autoimmune and collagen vascular disorders has been suggested.

Associations

Gross pathology

On gross pathology characteristic findings of Takayasu's arteritis are as follows:[5]

Microscopic pathology

On microscopic histopathological analysis characteristic findings of Takayasu's arteritis are as follows:[5]

H & E microscopy of a vessel showing vasculitis (inflammatory cells within the vessel wall), source:https://librepathology.org/wiki/Vasculitides#Takayasu_arteritis


References

  1. Inder SJ, Bobryshev YV, Cherian SM, Wang AY, Lord RS, Masuda K, Yutani C (March 2000). "Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions". Cardiovasc Surg. 8 (2): 141–8. PMID 10737351.
  2. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (January 1977). "Takayasu's arteritis. Clinical study of 107 cases". Am. Heart J. 93 (1): 94–103. PMID 12655.
  3. Salazar M, Varela A, Ramirez LA, Uribe O, Vasquez G, Egea E, Yunis EJ, Iglesias-Gamarra A (August 2000). "Association of HLA-DRB1*1602 and DRB1*1001 with Takayasu arteritis in Colombian mestizos as markers of Amerindian ancestry". Int. J. Cardiol. 75 Suppl 1: S113–6. PMID 10980348.
  4. Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R (August 2000). "Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis". Int. J. Cardiol. 75 Suppl 1: S77–83, discussion S85–7. PMID 10980341.
  5. 5.0 5.1 Gravanis MB (August 2000). "Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors". Int. J. Cardiol. 75 Suppl 1: S21–33, discussion S35–6. PMID 10980333.

Template:WH Template:WS